EUVIMEDEUVIMED entdecken
Crossref

Rewriting DNA in the body lowers cholesterol

Jocelyn Kaiser

Science · 2023

DOI: 10.1126/science.adm9506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2023. Verfasst von Jocelyn Kaiser. Hauptthemen laut MEDLINE: Cholesterol, LDL, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Verve Therapeutics says its base-editing approach may help prevent heart disease in many people

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLCRISPR-Cas SystemsGene EditingGenetic TherapyHyperaldosteronismProprotein Convertase 9HumansBase PairingDNAClinical Trials as Topic

Substanzen

Cholesterol, LDLDNAPCSK9 protein, humanProprotein Convertase 9

Zitieren

APA

Kaiser, J. (2023). Rewriting DNA in the body lowers cholesterol. Science. https://doi.org/10.1126/science.adm9506

Vancouver

Kaiser J. Rewriting DNA in the body lowers cholesterol. Science. 2023. doi:10.1126/science.adm9506

BibTeX
@article{Kaiser2023,
  author = {Kaiser, Jocelyn},
  title = {Rewriting DNA in the body lowers cholesterol},
  journal = {Science},
  year = {2023},
  doi = {10.1126/science.adm9506}
}
Kostenlos starten →